Peter Speelman

11.7k total citations · 1 hit paper
139 papers, 8.8k citations indexed

About

Peter Speelman is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Peter Speelman has authored 139 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Epidemiology, 49 papers in Infectious Diseases and 33 papers in Immunology. Recurrent topics in Peter Speelman's work include Immune Response and Inflammation (28 papers), Pneumonia and Respiratory Infections (21 papers) and Tuberculosis Research and Epidemiology (14 papers). Peter Speelman is often cited by papers focused on Immune Response and Inflammation (28 papers), Pneumonia and Respiratory Infections (21 papers) and Tuberculosis Research and Epidemiology (14 papers). Peter Speelman collaborates with scholars based in Netherlands, United States and Vietnam. Peter Speelman's co-authors include Ed J. Kuijper, Tom van der Poll, Jan M. Prins, Josbert J. Keller, Els van Nood, Sander J. H. van Deventer, Max Nieuwdorp, J. F. W. M. Bartelsman, Caroline E. Visser and Willem M. de Vos and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

Peter Speelman

136 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

2013 2.7k citations Peter Speelman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Speelman Netherlands	49	3.7k	3.4k	2.4k	1.6k	1.2k	139	8.8k
Evangelos J. Giamarellos‐Bourboulis Greece	58	2.1k 0.6×	4.4k 1.3×	2.8k 1.1×	3.8k 2.4×	2.6k 2.1×	436	13.7k
Cynthia L. Sears United States	66	4.6k 1.2×	2.1k 0.6×	8.5k 3.5×	1.9k 1.2×	1.9k 1.6×	221	16.5k
Y. Glupczynski Belgium	56	1.8k 0.5×	2.0k 0.6×	1.8k 0.8×	625 0.4×	3.0k 2.4×	262	10.6k
Jan Verhaegen Belgium	44	3.3k 0.9×	4.0k 1.2×	1.9k 0.8×	304 0.2×	601 0.5×	217	8.0k
Jaap T. van Dissel Netherlands	61	5.7k 1.5×	5.9k 1.8×	1.9k 0.8×	3.9k 2.4×	1.6k 1.3×	270	13.0k
Ville Valtonen Finland	42	1.3k 0.4×	2.6k 0.8×	1.4k 0.6×	1.2k 0.8×	1.7k 1.4×	143	9.4k
Alexander Swidsinski Germany	40	1.7k 0.4×	2.0k 0.6×	4.5k 1.9×	914 0.6×	1.4k 1.1×	80	8.4k
Carles Úbeda Spain	37	3.3k 0.9×	1.2k 0.4×	5.8k 2.4×	1.0k 0.6×	520 0.4×	56	9.3k
Laurent Beaugerie France	61	2.2k 0.6×	8.7k 2.6×	3.6k 1.5×	2.5k 1.6×	5.2k 4.3×	299	18.1k
Philippe Seksik France	49	3.0k 0.8×	4.7k 1.4×	7.4k 3.0×	1.3k 0.8×	3.1k 2.6×	191	14.5k

Countries citing papers authored by Peter Speelman

Since Specialization

Citations

This map shows the geographic impact of Peter Speelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Speelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Speelman more than expected).

Fields of papers citing papers by Peter Speelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Speelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Speelman. The network helps show where Peter Speelman may publish in the future.

Co-authorship network of co-authors of Peter Speelman

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Speelman. A scholar is included among the top collaborators of Peter Speelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Speelman. Peter Speelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Speelman, Peter, et al.. (2023). Divergent recovery trajectories of intertidal and subtidal coral communities highlight habitat-specific recovery dynamics following bleaching in an extreme macrotidal reef environment. PeerJ. 11. e15987–e15987. 2 indexed citations

Speelman, Peter, et al.. (2010). Performance of Dutch hospitals in the management of splenectomized patients. Journal of Hospital Medicine. 5(8). 466–470. 4 indexed citations

Steenbergen, Jim van, et al.. (2007). Een uitbraak van Q-koorts in Nederland--mogelijk verband met geiten. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 151(36). 1998–2003. 22 indexed citations

Verhagen, D.W.M., Jeroen Hermanides, Joke C. Korevaar, et al.. (2007). Extension of antimicrobial treatment in patients with left-sided native valve endocarditis based on elevated C-reactive protein values. European Journal of Clinical Microbiology & Infectious Diseases. 26(8). 587–590. 1 indexed citations

Schultsz, Constance, et al.. (2006). SWAB guidelines for antimicrobial therapy of acute infectious diarrhoea. The Netherlands Journal of Medicine. 64(11). 395–402.

Bresser, Paul, Rachida el Moussaoui, Frans H. Krouwels, et al.. (2006). Three vs. 10 days of amoxycillin–clavulanic acid for type 1 acute exacerbations of chronic obstructive pulmonary disease: a randomised, double-blind study. Clinical Microbiology and Infection. 13(3). 284–290. 15 indexed citations

Moussaoui, Rachida el, Brent C. Opmeer, Corianne A.J.M. de Borgie, et al.. (2006). Long-term Symptom Recovery and Health-Related Quality of Life in Patients With Mild-to-Moderate-Severe Community-Acquired Pneumonia. CHEST Journal. 130(4). 1165–1172. 62 indexed citations

Juffermans, Nicole P., Sebastiaan Weijer, Annelies Verbon, Peter Speelman, & Tom van der Poll. (2002). Expression of Human Immunodeficiency Virus Coreceptors CXC Chemokine Receptor 4 and CC Chemokine Receptor 5 on Monocytes Is Down‐regulated during Human Endotoxemia. The Journal of Infectious Diseases. 185(7). 986–989. 9 indexed citations

Rijneveld, Anita W., Marcel Levi, Sandrine Florquin, et al.. (2002). Urokinase Receptor Is Necessary for Adequate Host Defense Against Pneumococcal Pneumonia. The Journal of Immunology. 168(7). 3507–3511. 151 indexed citations

10.

Lauw, Fanny N., Judith Branger, Sandrine Florquin, et al.. (2002). IL-18 Improves the Early Antimicrobial Host Response to Pneumococcal Pneumonia. The Journal of Immunology. 168(1). 372–378. 87 indexed citations

11.

Olszyna, Dariusz P., Sandrine Florquin, Miguel E. Sewnath, et al.. (2001). CXC Chemokine Receptor 2 Contributes to Host Defense in Murine Urinary Tract Infection. The Journal of Infectious Diseases. 184(3). 301–307. 46 indexed citations

12.

Rijneveld, Anita W., Sandrine Florquin, Judith Branger, et al.. (2001). TNF-α Compensates for the Impaired Host Defense of IL-1 Type I Receptor-Deficient Mice During Pneumococcal Pneumonia. The Journal of Immunology. 167(9). 5240–5246. 103 indexed citations

13.

Schultz, Marc J., Jan Wijnholds, Maikel P. Peppelenbosch, et al.. (2001). Mice Lacking the Multidrug Resistance Protein 1 Are Resistant to Streptococcus pneumoniae- Induced Pneumonia. The Journal of Immunology. 166(6). 4059–4064. 52 indexed citations

14.

Wingate, D. L., S. F. Phillips, Stephen J. Lewis, et al.. (2001). Guidelines for adults on self‐medication for the treatment of acute diarrhoea. Alimentary Pharmacology & Therapeutics. 15(6). 773–782. 55 indexed citations

15.

Schultz, Marc J., et al.. (2000). The effect ofPseudomonasexotoxin A on cytokine production in whole blood exposed toPseudomonas aeruginosa. FEMS Immunology & Medical Microbiology. 29(3). 227–232. 25 indexed citations

16.

Juffermans, Nicole P., Annelies Verbon, John T. Belisle, et al.. (2000). Mycobacterial Lipoarabinomannan Induces an Inflammatory Response in the Mouse Lung. American Journal of Respiratory and Critical Care Medicine. 162(2). 486–489. 28 indexed citations

17.

Olszyna, Dariusz P., Jan M. Prins, Pascale E. P. Dekkers, et al.. (1999). Sequential Measurements of Chemokines in Urosepsis and Experimental Endotoxemia. Journal of Clinical Immunology. 19(6). 399–405. 35 indexed citations

18.

Juffermans, Nicole P., Annelies Verbon, Sander J. H. van Deventer, et al.. (1998). Tumor Necrosis Factor and Interleukin-1 Inhibitors as Markers of Disease Activity of Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 157(4). 1328–1331. 71 indexed citations

19.

Speelman, Peter, et al.. (1996). Piperacillin To Prevent Cholangitis after Endoscopic Retrograde Cholangiopancreatography. Annals of Internal Medicine. 6 indexed citations

20.

Crevel, Reinout van, Peter Speelman, Claudia Gravekamp, & W. J. Terpstra. (1994). Leptospirosis in Travelers. Clinical Infectious Diseases. 19(1). 132–134. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact